Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program.
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MCCLEARY, Nadine Jackson | |
dc.contributor.author | HARMSEN, William S. | |
dc.contributor.author | VANCUTSEM, Eric | |
dc.contributor.author | SOBRERO, Alberto F. | |
dc.contributor.author | GOLDBERG, Richard M. | |
dc.contributor.author | TABERNERO, Josep | |
dc.contributor.author | SEYMOUR, Matt | |
dc.contributor.author | SALTZ, Leonard B. | |
dc.contributor.author | GIANTONIO, Bruce J. | |
dc.contributor.author | DIRK, Arnold | |
dc.contributor.author | ROTHENBERG, Mace L. | |
dc.contributor.author | KOOPMAN, Miriam | |
dc.contributor.author | SCHMOLL, Hans-Joachim Hans-Joachim | |
dc.contributor.author | PITOT, Henry C. | |
dc.contributor.author | HOFF, Paulo Marcelo | |
dc.contributor.author | FALCONE, Alfredo | |
dc.contributor.author | GRAMONT, Aimery De | |
dc.contributor.author | SHI, Qian | |
dc.contributor.author | LICHTMAN, Stuart M. | |
dc.date.accessioned | 2020-06-17T11:39:30Z | |
dc.date.available | 2020-06-17T11:39:30Z | |
dc.date.issued | 2020 | |
dc.description.conferencedate | JAN 23-25, 2020 | |
dc.description.conferencelocal | San Francisco, CA | |
dc.description.conferencename | Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology | |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | NIH/NCI Gastrointestinal SPORE Dana-Farber/Harvard Cancer Center | |
dc.identifier.citation | JOURNAL OF CLINICAL ONCOLOGY, v.38, n.4, suppl.S, 2020 | |
dc.identifier.eissn | 1527-7755 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/36374 | |
dc.language.iso | eng | |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | eng |
dc.relation.ispartof | Journal of Clinical Oncology | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright AMER SOC CLINICAL ONCOLOGY | eng |
dc.subject.wos | Oncology | eng |
dc.title | Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program. | eng |
dc.type | conferenceObject | eng |
dc.type.category | meeting abstract | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.contributor.author-fmusphc | HOFF, Paulo Marcelo | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.issue | suppl S | |
hcfmusp.description.volume | 38 | |
hcfmusp.jcr | J CLIN ONCOL | |
hcfmusp.origem | WOS | |
hcfmusp.origem.wos | WOS:000530922700007 | |
hcfmusp.publisher.city | ALEXANDRIA | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.sjr | 29949 | |
relation.isAuthorOfPublication | 706efa42-09fc-4065-8330-9391f2cbe840 | |
relation.isAuthorOfPublication.latestForDiscovery | 706efa42-09fc-4065-8330-9391f2cbe840 |